Olicon slashes sales force for OEM focus

Article

PACS and teleradiology vendor Olicon Imaging Systems has apparently cut its direct sales force to focus on its OEM relationship with healthcare information systems firm Shared Medical Systems. Olicon executives declined to return calls seeking comment,

PACS and teleradiology vendor Olicon Imaging Systems has apparently cut its direct sales force to focus on its OEM relationship with healthcare information systems firm Shared Medical Systems. Olicon executives declined to return calls seeking comment, but a source close to the situation confirmed the reduction in Olicon’s direct sales force and change in the Aliso Viejo, CA-based company’s direction.

The two firms signed an agreement in August that would allow SMS to offer Olicon’s diagnostic workstations and PACSView teleradiology offerings to its customers. That deal built on a relationship in evidence at the 1997 Radiological Society of North America meeting, where Olicon workstations were displayed in the booth of Malvern, PA-based SMS (SCAN Special Report 12/97). Olicon will be keeping its booth at this year’s RSNA meeting, according to a RSNA source.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.